MetaCap

Claritev (CTEV) vs Evolent Health (EVH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Evolent Health (EVH) has outperformed Claritev (CTEV) over the past year, losing 49.0% versus a loss of 55.0%. Over five years, EVH leads with a -86.2% price change compared with -86.5% for CTEV. Evolent Health is the larger company by market cap ($468.1 million vs $424.2 million), about 1.1 times the size.

On valuation, Claritev trades at a lower forward P/E (3.4x vs 10.3x for Evolent Health).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTEV-55.01%EVH-49.01%
+33%-24%-81%
Oct 7, 20251 yearOct 7, 2026
CTEV-87.61%EVH-87.86%
+22%-41%-103%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTEV versus EVH key metrics
MetricCTEVEVH
Share price$25.03$4.14
Market cap$424.20M$468.07M
1-day change+3.90%+7.81%
YTD return-41.45%+3.50%
1-year return-55.01%-49.01%
5-year return-86.51%-86.17%
Forward P/E3.4110.25
EPS (TTM)$-17.66$-4.49
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$73.68$8.34
52-week low$11.50$2.10
Distance from 52-week high-66.03%-50.33%
Analyst consensusbuybuy
Avg. price target upside+83.78%+38.89%
Average volume133.69K2.97M
Shares outstanding16.95M113.06M
Employees3,0004,200
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesOther Consumer Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Claritev

CTEV stock →

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.

Consumer Discretionary · Business Services · 3,000 employees

About Evolent Health

EVH stock →

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management.

Consumer Discretionary · Other Consumer Services · 4,200 employees

CTEV vs EVH FAQ

Which is bigger, Claritev or Evolent Health?

Evolent Health (EVH) is larger, with a market capitalization of $468.07M compared with $424.20M for Claritev (CTEV).

Which stock has performed better over the past year, CTEV or EVH?

EVH returned -49.01% over the past 12 months, compared with -55.01% for CTEV (price return, excluding dividends). Past performance does not predict future results.

Are Claritev and Evolent Health in the same industry?

Both are in the Consumer Discretionary sector, but in different industries: Business Services for Claritev and Other Consumer Services for Evolent Health.

More comparisons